| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | EP1524975B9 Improved transdermal delivery system for the administration of rotigotine |
| 02/22/2012 | EP1514542B1 Medicinal composition comprising Tacrine or Donepezil for improving brain function. |
| 02/22/2012 | EP1389121B1 Method and compositions for treating mammalian nerve tissue injuries |
| 02/22/2012 | EP1163029B1 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 02/22/2012 | CN1903250B 一种丹参药材的提取分离方法 A method for the extraction and separation of herbs Salvia |
| 02/22/2012 | CN1854151B 多巴胺转运蛋白拟肽抑制剂及其应用 Peptidomimetic inhibitor of dopamine transporter and its application |
| 02/22/2012 | CN102361873A Fused pyrimidine-dione derivatives as trpa1 modulators |
| 02/22/2012 | CN102361862A Thiophenyl sulfonamides for the treatment of alzheimer's disease |
| 02/22/2012 | CN102361860A Benzothiadiazepine derivatives used as AMPA and NMDA receptor modulators |
| 02/22/2012 | CN102361645A Composition for prevention or treatment of insomnia |
| 02/22/2012 | CN102361639A Adhesive patch-containing package bag and method for storing adhesive patch |
| 02/22/2012 | CN102361638A Transdermal preparation |
| 02/22/2012 | CN102361635A Coated solid preparation |
| 02/22/2012 | CN102360015A Anti-alzheimer's disease monoclonal antibody and application thereof |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102358735A Low toxicity multiple independently target able drugs-nitrogen aromatic ring-containing CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 02/22/2012 | CN102358730A Micromolecular methyl ethyl ketone (MEK) protein kinase inhibitor |
| 02/22/2012 | CN102358721A More stable aceglutamide compound and medicinal composition thereof |
| 02/22/2012 | CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/22/2012 | CN102357240A Traditional Chinese medicine for treating peripheral vascular functional disease of Raynaud disease |
| 02/22/2012 | CN102357238A Traditional Chinese medicine combination for treating prosopalgia |
| 02/22/2012 | CN102357237A Chinese medicine composition for treating elderly intractable insomnia |
| 02/22/2012 | CN102357236A Traditional Chinese medicine for treating facial neuritis |
| 02/22/2012 | CN102357230A Traditional Chinese medicine preparation for treating radiation encephalopathy |
| 02/22/2012 | CN102357225A Traditional Chinese medicine composition for curing insomnia |
| 02/22/2012 | CN102357175A Traditional Chinese medicine composite for regulating nervous system dysfunction and application thereof |
| 02/22/2012 | CN102357169A Traditional Chinese medicine composition for treating dysthymia |
| 02/22/2012 | CN102357166A Brain tonic powder and application thereof |
| 02/22/2012 | CN102357149A Health product with sedative and hypnotic functions |
| 02/22/2012 | CN102357134A Medicine for preventing and treating Alzheimer disease and cerebral thrombosis and preparation method thereof |
| 02/22/2012 | CN102357122A Masking type Chailian oral liquid and preparation method thereof |
| 02/22/2012 | CN102357115A Sugar-free compound wintercreeper mixture and production method thereof |
| 02/22/2012 | CN102357091A Chlocibutamine slow release pharmaceutical composition |
| 02/22/2012 | CN102078381B 一种防治神经衰弱的药物及其制备方法 A drug and its preparation method of prevention and treatment of neurasthenia |
| 02/22/2012 | CN102000334B 用于治疗抑郁症的复方制剂 For the treatment of depression compound preparation |
| 02/22/2012 | CN101766579B 一种度洛西汀的缓释肠溶制剂及其芯材和制备方法 One kind of duloxetine enteric sustained-release preparation and preparation of the core material and |
| 02/22/2012 | CN101757510B 一种治疗坐骨神经痛的中药 A traditional Chinese medicine treatment of sciatica |
| 02/22/2012 | CN101745065B 一种具有抗癌止痛作用的药物组合物 A pharmaceutical composition having an anticancer analgesic effect |
| 02/22/2012 | CN101675932B 一种防治肌萎缩侧索硬化的组合物 A composition amyotrophic lateral sclerosis prevention |
| 02/22/2012 | CN101642510B 一种治疗重症躁狂症的中药组合物及其制备方法 A severe mania Chinese medicine composition and its preparation method of treatment |
| 02/22/2012 | CN101631534B 用于跨膜给药对乙酰氨基酚的盖仑制剂 For transmembrane administration of acetaminophen galenical |
| 02/22/2012 | CN101574348B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method |
| 02/22/2012 | CN101550174B 2-氨基-4-(4-β-D-吡喃阿洛糖苷-苯基)-6-苯基-嘧啶及其制备方法与应用 2-amino -4- (4-β-D- glucoside pyran Alor - phenyl) -6-phenyl - pyrimidine and its preparation method and application |
| 02/22/2012 | CN101384279B 抗淀粉样蛋白免疫原性组合物、方法和用途 Anti-amyloid immunogenic compositions, methods and uses |
| 02/22/2012 | CN101269148B 用于预防出生缺陷并改善记忆的药物组合物 For the prevention of birth defects, and a pharmaceutical composition for improving memory |
| 02/22/2012 | CN101269128B 用于预防出生缺陷和改善记忆的药物组合物 For the prevention of birth defects and a pharmaceutical composition for improving memory |
| 02/22/2012 | CN101263849B 三花解烟仙茶 Three flower fairy tea smoke Solutions |
| 02/22/2012 | CN101247794B 阿肽地尔的制剂 A peptide formulations Seoul |
| 02/22/2012 | CN101003526B 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/21/2012 | US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119659 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/21/2012 | US8119644 Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 02/21/2012 | US8119635 Diazabicyclic central nervous system active agents |
| 02/21/2012 | US8119633 Substituted sulfonamide compounds |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119621 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 02/21/2012 | US8119619 Pregnane steroids and their use in the treatment of CNS disorders |
| 02/21/2012 | US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease |
| 02/21/2012 | US8119370 Activatable recombinant neurotoxins |
| 02/21/2012 | US8119166 Methods of treatment using a gastric retained gabapentin dosage |
| 02/21/2012 | US8119163 Nanoparticulate and controlled release compositions comprising cefditoren |
| 02/21/2012 | US8119148 Oxcarbazepine suspension; oral administering |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | US8119114 Polymer conjugates of mutated neublastin |
| 02/21/2012 | CA2544136C Use of agomelatin in the formulation of drugs for the treatment of bipolar disorders |
| 02/21/2012 | CA2540109C Method for stabilization of diarylvinylene compounds |
| 02/21/2012 | CA2534585C Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2478542C Aminoindazole derivatives, their method of preparation and intermediaries of this process as medicines and pharmaceutical compositions containing same |
| 02/21/2012 | CA2472399C Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 02/21/2012 | CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2439123C Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 02/21/2012 | CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/21/2012 | CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system |
| 02/16/2012 | WO2012021854A2 Treatment of penetrative injury to the brain |
| 02/16/2012 | WO2012021800A2 Caspase inhibitors as therapeutics for neural and organ injury and imaging |
| 02/16/2012 | WO2012021788A2 Dipeptide calpain inhibitors |
| 02/16/2012 | WO2012021647A2 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof |
| 02/16/2012 | WO2012021558A1 Methods and compositions for preventing a condition |
| 02/16/2012 | WO2012021469A1 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| 02/16/2012 | WO2012020991A2 Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients |
| 02/16/2012 | WO2012020897A1 Model mouse of attention deficit hyperactivity disorder, method for investigating effects for preventing and alleviating attention disorder using the model mouse, and method for treating attention disorder by suppressing t-type calcium channel |
| 02/16/2012 | WO2012020848A1 Heterocyclic compound and use thereof |
| 02/16/2012 | WO2012020820A1 Heteroaryl-pyrazole derivative |
| 02/16/2012 | WO2012020813A1 Fused-ring pyrrolidine derivative |
| 02/16/2012 | WO2012020780A1 Heterocyclic compound and use thereof |
| 02/16/2012 | WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 02/16/2012 | WO2012020738A1 Heterocyclic compound and use thereof |
| 02/16/2012 | WO2012020726A1 Inhibitor of casein kinase 1δ and casein kinase 1ε |
| 02/16/2012 | WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers |
| 02/16/2012 | WO2012020423A1 Role of an herbal formulation in the prevention and management of age related neurodegenerative disorders with special reference to senile dementia |
| 02/16/2012 | WO2012020389A1 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof |
| 02/16/2012 | WO2012020270A1 Use of radiprodil in attention deficit hyperactivity disorder |
| 02/16/2012 | WO2012020258A1 New use of milbemycin derivatives |